Mandate

Vinge has advised Smart Eye in connection with a capital procurement of MSEK 275

Vinge has advised Smart Eye Aktiebolag (publ) in connection with a directed new share issue of MSEK 275. The subscription price, which is equivalent to the closing price of the shares on First North Growth Market, was determined via a so-called accelerated book building procedure led by Carnegie.

Vinge’s team consisted of Anders Strid, Edin Agic and Hampus Olsson.

Related

Vinge has advised Oncopeptides in connection with a directed share issue

Vinge has advised Oncopeptides in connection with a directed share issue, whereby Oncopeptides raises proceeds of SEK 100 million.
October 16, 2026

Vinge advises KGAL on its divestment of a Nordic wind portfolio to Enordic Evergreen

Vinge has advised KGAL on the divestment of a Nordic onshore wind portfolio to Enordic Evergreen.
October 14, 2026

Vinge has advised Orexo in connection with its rights issue

Vinge has advised Orexo AB (publ) in connection with a partially guaranteed rights issue of approximately SEK 250 million before transaction costs, subject to approval by an extraordinary general meeting.
October 09, 2026